Glaukos Corporation ( GKOS) - Key Metrics
GKOS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.49 | -$2.32 | $0.12 | $0.07 |
| 2025Q3 | $2.34 | -$0.28 | -$0.18 | -$0.21 |
| 2025Q2 | $2.18 | -$0.35 | $0.12 | $0.10 |
| 2025Q1 | $1.88 | -$0.32 | -$0.33 | -$0.36 |
GKOS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -12.14 |
| 2025Q3 | ? | -71.70 |
| 2025Q2 | ? | -74.78 |
| 2025Q1 | ? | -76.80 |
GKOS
Price: $129.28
52 week price:
Earnings Per Share: -3.19 USD
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 62314
Ebitda: 2.3 millionMarket Capitalization: 7.3 billion